keyword
MENU ▼
Read by QxMD icon Read
search

her2 moa

keyword
https://www.readbyqxmd.com/read/29868123/a-leveraged-signal-to-noise-ratio-lstnr-method-to-extract-differentially-expressed-genes-and-multivariate-patterns-of-expression-from-noisy-and-low-replication-rnaseq-data
#1
Oswaldo A Lozoya, Janine H Santos, Richard P Woychik
To life scientists, one important feature offered by RNAseq, a next-generation sequencing tool used to estimate changes in gene expression levels, lies in its unprecedented resolution. It can score countable differences in transcript numbers among thousands of genes and between experimental groups, all at once. However, its high cost limits experimental designs to very small sample sizes, usually N = 3, which often results in statistically underpowered analysis and poor reproducibility. All these issues are compounded by the presence of experimental noise, which is harder to distinguish from instrumental error when sample sizes are limiting (e...
2018: Frontiers in Genetics
https://www.readbyqxmd.com/read/26938945/trastuzumab-debouganin-conjugate-overcomes-multiple-mechanisms-of-t-dm1-drug-resistance
#2
Rachelle L Dillon, Shilpa Chooniedass, Arjune Premsukh, Gregory P Adams, Joycelyn Entwistle, Glen C MacDonald, Jeannick Cizeau
The development of antibody drug conjugates has provided enhanced potency to tumor-targeting antibodies by the addition of highly potent payloads. In the case of trastuzumab-DM1 (T-DM1), approved for the treatment of metastatic breast cancer, the addition of mertansine (DM1) to trastuzumab substantially increased progression-free survival. Despite these improvements, most patients eventually relapse due to complex mechanisms of resistance often associated with small molecule chemotherapeutics. Therefore, identifying payloads with different mechanisms of action (MOA) is critical for increasing the efficacy of targeted therapeutics and ultimately improving patient outcomes...
April 2016: Journal of Immunotherapy
https://www.readbyqxmd.com/read/23744663/estimating-conditional-probabilities-for-the-detection-of-unfavorable-copy-number-alterations-in-a-targeted-therapy
#3
Fang-Han Hsu, Edward R Dougherty, Yidong Chen, Erchin Serpedin
Emerging targeted therapies have shown benefits such as less toxicity and higher effectiveness in specific types of cancer treatment; however, the accessibility of these advantages may rely on correct identification of suitable patients, which remains highly immature. We assume that copy number profiles, being accessible genomic data via microarray techniques, can provide useful information regarding drug response and shed light on personalized therapy. Based on the mechanism of action (MOA) of trastuzumab in the HER2 signaling pathway, a Bayesian network model in which copy number alterations (CNAs) serve as latent parents modifying signal transduction is applied...
October 2013: IEEE Transactions on Bio-medical Engineering
1
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"